The RISE study protocol: resilience impacted by positive stressful events for people with cystic fibrosis
Introduction For people with cystic fibrosis (CF), gaining access to elexacaftor/tezacaftor/ivacaftor (ETI) therapy, a new modulator drug combination, is perceived as a positive life event. ETI leads to a strong improvement of disease symptoms. However, some people with CF experience a deterioration...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2023-06-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/9/3/00535-2022.full |